NVIDIA champions Innophore partnership to model drug dynamics with AI
NVIDIA and Innophore’s collaborative artificial intelligence (AI)-driven, drug safety screening platform CavitOmiX is set to launch in late January 2025,…
21 Jan 2025
AI’s potential in the women’s health exciting, says Gates Foundation leader
The health disparity between women and men is a pressing global challenge, experts highlighted in a discussion at the World Economic Forum Annual Meeting 2025 in Switzerland. Despite comprising half…
21 Jan 2025
J&Js Lazcluze/Rybrevant combination obtains European approval to treat NSCLC
Johnson & Johnson’s (J&J) combination therapy of Lazcluze (lazertinib) and Rybrevant (amivantamab-vmjw) has been granted marketing authorisation by the European Commission (EC) as a first-line treatment for patients with some…
21 Jan 2025
Junshi partners LEO Pharma for toripalimab distribution in Europe
Shanghai Junshi Biosciences and its subsidiary TopAlliance Biosciences are set to enter a collaboration with LEO Pharma to distribute and market the monoclonal antibody, toripalimab, in Europe. The agreement focuses…
21 Jan 2025
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trial
South African biotech Afrigen Biologics has secured a $6.2m grant from the Coalition for Epidemic Preparedness Innovations (CEPI) to develop the first mRNA-based vaccine against Rift Valley fever. The funding…
21 Jan 2025
Trump signs executive order to leave World Health Organization
President Donald Trump has signed an executive order for the US to leave the World Health Organization (WHO). As one of his first acts as the 47th President of the…
21 Jan 2025
Health Canada gives Takeda’s mCRC capsules market authorisation
Health Canada has granted market authorisation to Takeda Canada for FRUZAQLA (fruquintinib) capsules to treat adults with metastatic colorectal cancer (mCRC). The authorisation is intended for patients who have exhausted…